
Extracorporeal shockwave therapy (ESWT) is a novel treatment modality to stimulate tissue regeneration and anti-fibrosis. In this review, we summarise the use of ESWT for erectile dysfunction (ED), diabetic foot ulcers (DFU), Peyronie's disease (PD), chronic kidney disease (CKD), and scleroderma. Several randomised clinical trials demonstrate the efficacy of ESWT for vasculogenic ED and DFU, and ESWT may also relieve pain in patients with PD. ESWT is still experimental for CKD and scleroderma. In general, ESWT is associated with few and mild adverse effects.
Extracorporeal Shockwave Therapy, Male, Treatment Outcome, Erectile Dysfunction, Penile Induration, Humans, Diabetic Foot
Extracorporeal Shockwave Therapy, Male, Treatment Outcome, Erectile Dysfunction, Penile Induration, Humans, Diabetic Foot
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
